18F-FMT PET (%) | 18F-FDG PET (%) | |||||
---|---|---|---|---|---|---|
Patient group | SUV ≤ 1.6 (low) | SUV > 1.6 (high) | P (log-rank test) | SUV ≤ 11 (low) | SUV > 11 (high) | P (log-rank test) |
Total patients (n = 98) | n = 49 | n = 49 | n = 77 | n = 21 | ||
OS | 75 | 46.7 | 0.0129 | 67.2 | 40.9 | 0.0481 |
DFS | 41.8 | 28.8 | 0.0280 | 40.3 | 25.0 | 0.1254 |
AC (n = 57) | n = 32 | n = 25 | n = 45 | n = 12 | ||
OS | 81.5 | 37.7 | 0.0027 | 65.8 | 31.7 | 0.0185 |
DFS | 46.5 | 27.4 | 0.0338 | 39.9 | 22.8 | 0.2501 |
Non-AC (n = 41) | n = 17 | n = 24 | n = 33 | n = 8 | ||
OS | 51.9 | 49.6 | 0.6836 | 46.9 | 60.0 | 0.9729 |
AC = adenocarcinoma.